Cellectis S.A.

NASDAQ: CLLS
Share price (12/20/24): $1.64
Market cap (12/20/24): $164 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022 – amended

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Bpifrance Participations SA

Long Focus Capital Management, LLC

Baillie Gifford & Co

AstraZeneca PLC

News Filter

Announces the Drawdown of the Third Tranche of €5 Million Under the Credit Facility Agreement Entered With the European Investment Bank

Presents Multiple Strategies to Enhance CAR T-Cell Efficacy in Solid Tumors at the SITC Annual Meeting

Preliminary Note

To Report Third Quarter 2024 Financial Results on November 4, 2024

To Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Confidential treatment order

Confidential treatment order